HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Delayed diagnosis of angiosarcoma of the spleen: clinically presenting as recurrent haemoperitoneum following embolisation.

Abstract
Angiosarcoma is a highly aggressive and extremely rare neoplasm of the spleen, with a limited number of reported cases worldwide. We report a case of a 69-year-old man who presented with progressive symptoms of fatigue, abdominal and back pain, anaemia and haemoperitoneum 1 year following embolisation of the spleen for splenic rupture. Additional imaging and colonoscopy with biopsy revealed intra-abdominal fluid and a colonic adenocarcinoma. Diagnostic laparoscopy demonstrated a haemoperitoneum and colon carcinoma, after which splenectomy via laparotomy was performed. Pathology report revealed an angiosarcoma of the spleen with peritoneal tumour deposits. Rupturing of a spleen may be due to an underlying disease. Therefore, the differential diagnosis of splenic rupture should include the possibility of a splenic tumour. The definitive diagnosis and treatment of a splenic angiosarcoma may require splenectomy, although prognosis is poor.
AuthorsVerena Kornmann, Philip van Rijn, Dries Mulder, Koen Reijnders
JournalBMJ case reports (BMJ Case Rep) Vol. 2015 (Apr 09 2015) ISSN: 1757-790X [Electronic] England
PMID25858933 (Publication Type: Case Reports, Journal Article)
Copyright2015 BMJ Publishing Group Ltd.
Topics
  • Aged
  • Delayed Diagnosis
  • Diagnosis, Differential
  • Embolization, Therapeutic (methods)
  • Hemangiosarcoma (complications, diagnosis, pathology)
  • Hemoperitoneum (diagnosis, etiology, therapy)
  • Humans
  • Laparotomy (methods)
  • Male
  • Prognosis
  • Spleen (pathology, surgery)
  • Splenectomy (methods)
  • Splenic Neoplasms (complications, diagnosis, pathology)
  • Splenic Rupture (etiology, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: